Skip to main content

Table 2 Experimental arm drug doses by weight bands {11a}

From: Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial

Druga

Weight band (kg)

30–35

>35–45

>45–55

>55–70

>70

Bedaquiline

400 mg QD x 2 weeksb followed by 200 mg 3x/week

Delamanid

100 mg BID

Moxifloxacin

400 mg

Levofloxacin

750 mg

1000 mg

Linezolidc

600 mg QD up to week 16 (followed by 300 mg QD or 600 mg 3×/week)

Clofazimine

100 mg

Pyrazinamide

800 mg

1200 mg

1600 mg

2000 mg

  1. aDosing is once a day unless otherwise indicated
  2. bThe loading dose of bedaquiline treatment comprises 2 weeks of 400 mg QD. If the patient is already receiving bedaquiline treatment, bedaquiline within the experimental regimen should be dosed as a continuation of that treatment (i.e. only remaining doses of the 2-week loading dose should be administered and a load should not be restarted if it was already completed at time of study treatment initiation)
  3. cLinezolid dosing is routinely modified at week 16 or sooner if necessary to reduce toxicity related to linezolid. The modification entails either decreased (300 mg daily) or intermittent (600 mg 3×/week) dosing as defined by balanced randomization